These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 18588872

  • 21. Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents.
    Coley HM, Shotton CF, Ajose-Adeogun A, Modjtahedi H, Thomas H.
    Biochem Pharmacol; 2006 Oct 16; 72(8):941-8. PubMed ID: 16934227
    [Abstract] [Full Text] [Related]

  • 22. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
    Yeh J, Litz J, Hauck P, Ludwig DL, Krystal GW.
    Lung Cancer; 2008 May 16; 60(2):166-74. PubMed ID: 18006183
    [Abstract] [Full Text] [Related]

  • 23. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells.
    Lee DH, Szczepanski MJ, Lee YJ.
    J Cell Biochem; 2009 Apr 15; 106(6):1113-22. PubMed ID: 19229860
    [Abstract] [Full Text] [Related]

  • 24. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
    Saggar JK, Chen J, Corey P, Thompson LU.
    Mol Nutr Food Res; 2010 Mar 15; 54(3):415-25. PubMed ID: 19904759
    [Abstract] [Full Text] [Related]

  • 25. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP, Ngoubilly N, Neavyn M, Lanza-Jacoby S.
    J Surg Res; 2006 May 15; 132(2):208-13. PubMed ID: 16580691
    [Abstract] [Full Text] [Related]

  • 26. Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.
    Zhang X, Chen S, Wang Y.
    Eur J Pharmacol; 2007 Jan 05; 554(1):1-7. PubMed ID: 17109844
    [Abstract] [Full Text] [Related]

  • 27. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy.
    Ling B, Liang SF, Xu YH, Zhao XY, Tang MH, Liu XY, Zhao X, Huang CH, Chen LJ, Wei YQ.
    Amino Acids; 2008 Jun 05; 35(1):115-22. PubMed ID: 18157584
    [Abstract] [Full Text] [Related]

  • 28. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2009 Sep 05; 117(2):261-71. PubMed ID: 18815881
    [Abstract] [Full Text] [Related]

  • 29. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR.
    Clin Cancer Res; 2010 May 01; 16(9):2571-9. PubMed ID: 20388852
    [Abstract] [Full Text] [Related]

  • 30. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
    Lee SJ, Cho YH, Park K, Kim EJ, Jung KH, Park SS, Kim WJ, Moon SK.
    Biochem Pharmacol; 2008 Jun 15; 75(12):2289-300. PubMed ID: 18468578
    [Abstract] [Full Text] [Related]

  • 31. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H, Scholz C, Zang C, Schefe JH, Habbel P, Regierer AC, Schulz CO, Possinger K, Eucker J.
    Anticancer Res; 2012 May 15; 32(5):1627-37. PubMed ID: 22593441
    [Abstract] [Full Text] [Related]

  • 32. Honokiol synergizes chemotherapy drugs in multidrug resistant breast cancer cells via enhanced apoptosis and additional programmed necrotic death.
    Tian W, Deng Y, Li L, He H, Sun J, Xu D.
    Int J Oncol; 2013 Feb 15; 42(2):721-32. PubMed ID: 23242346
    [Abstract] [Full Text] [Related]

  • 33. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations.
    Serra V, Markman B, Scaltriti M, Eichhorn PJ, Valero V, Guzman M, Botero ML, Llonch E, Atzori F, Di Cosimo S, Maira M, Garcia-Echeverria C, Parra JL, Arribas J, Baselga J.
    Cancer Res; 2008 Oct 01; 68(19):8022-30. PubMed ID: 18829560
    [Abstract] [Full Text] [Related]

  • 34. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM, Virnig C, Cance WG.
    Mol Carcinog; 2008 Mar 01; 47(3):222-34. PubMed ID: 17849451
    [Abstract] [Full Text] [Related]

  • 35. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
    Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F.
    Cancer Res; 2006 Mar 15; 66(6):3238-47. PubMed ID: 16540676
    [Abstract] [Full Text] [Related]

  • 36. Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    Li Z, Liu Y, Zhao X, Pan X, Yin R, Huang C, Chen L, Wei Y.
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep 15; 140(1):95-102. PubMed ID: 18440692
    [Abstract] [Full Text] [Related]

  • 37. [Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine].
    Huang YH, Zhang SH, Zhen RX, Xu XD, Zhen YS.
    Ai Zheng; 2004 Dec 15; 23(12):1599-604. PubMed ID: 15601545
    [Abstract] [Full Text] [Related]

  • 38. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
    Wang X, Yuan S, Wang J, Lin P, Liu G, Lu Y, Zhang J, Wang W, Wei Y.
    Toxicol Appl Pharmacol; 2006 Sep 01; 215(2):168-78. PubMed ID: 16563451
    [Abstract] [Full Text] [Related]

  • 39. Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants.
    Chefrour M, Milano G, Formento P, Giacometti S, Denden A, Renée N, Iliadis A, Fischel JL, Ciccolini J.
    Fundam Clin Pharmacol; 2012 Aug 01; 26(4):530-7. PubMed ID: 21623901
    [Abstract] [Full Text] [Related]

  • 40. Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer.
    Lanza-Jacoby S, Burd R, Rosato FE, McGuire K, Little J, Nougbilly N, Miller S.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6161-9. PubMed ID: 17062693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.